Fulgent Genetics (FLGT) Shares Outstanding (2015 - 2026)

Fulgent Genetics has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $28.0 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) fell 8.5% year-over-year to $28.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $28.0 million (down 8.5% YoY) and the FY2025 annual result came in at $31.1 million, up 0.78% from the prior year.
• Shares Outstanding (Entity) slipped to $28.0 million in Q2 2026 per FLGT's latest filing, from $28.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $31.9 million in Q3 2023 and troughed at $28.0 million in Q2 2026.
• A 5-year average of $30.5 million and a median of $30.6 million in 2025 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) rose 4.62% in 2022, then dropped 8.5% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $31.2 million in 2022, then dropped by 5.1% to $29.7 million in 2023, then climbed by 4.01% to $30.8 million in 2024, then grew by 0.78% to $31.1 million in 2025, then fell by 9.9% to $28.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $28.0 million, $28.9 million, and $31.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.